10/13/2026
You’ve probably heard plenty about GLP-1 medications for weight loss. But what if their potential health benefits extend far beyond the number on the scale?
Did you know❓
➡️ Heart health: In a major clinical trial, semaglutide reduced the relative risk of major cardiovascular events by 20% in adults with established cardiovascular disease and overweight or obesity—even without diabetes.
➡️ Kidney protection: Clinical trials have demonstrated meaningful kidney benefits in certain patients with type 2 diabetes and chronic kidney disease.
➡️ Brain health: Researchers are investigating whether GLP-1 medications may influence neuroinflammation, cognitive health, and neurodegenerative disease.
➡️ Cravings and reward pathways: Early research suggests these medications may affect more than appetite, potentially influencing alcohol cravings and other reward-driven behaviors.
➡️ Metabolic health: Benefits can extend beyond weight reduction, including improvements in blood sugar regulation and insulin sensitivity.
Whether you’re currently taking a GLP-1 medication, considering one, or simply curious about the science, this conversation is for you.
Registration is required. Spots limited to 25. Email [email protected] to register with the subject “RSVP ME.”
Bring your curiosity. Bring your questions.